Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Vavalle

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Cardiovascular Diagnosis and Therapy|March 17, 2020
Percutaneous structural and valvular heart disease interventionsJohn P Vavalle, Sameer Arora
Journal of Thrombosis and Thrombolysis|January 19, 2026
Refining the evidence base for anticoagulation in HALT following TAVRSpencer Ng, John P Vavalle
Journal of Thoracic Disease|June 16, 2017
Minimally invasive aortic valve replacement-where are we?Sameer Arora, John P Vavalle
JACC. Heart Failure|April 30, 2021
Reply: Mitral Regurgitation in Heart Failure: Prognostic Significance and Impact on Evaluation of Left Ventricular FunctionSameer Arora, John P Vavalle
Annals of Cardiothoracic Surgery|October 25, 2017
Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidenceSameer Arora, John P Vavalle
JACC. Cardiovascular Interventions|October 23, 2020
Atrial Fibrillation: Not an Innocent Bystander in the Treatment of Functional Mitral RegurgitationJohn P Vavalle, Sameer Arora
Trends in Cardiovascular Medicine|November 8, 2020
Editorial commentary: Asymptomatic aortic stenosis, moderate aortic stenosis with systolic heart failure and bicuspid aortic valve stenosis- is TAVR ready for prime time?Sameer Arora, John P Vavalle
Trends in Cardiovascular Medicine|September 9, 2017
Editorial commentary: TAVR-Is there a path to an all-surgical-risk indication?Sameer Arora, John P Vavalle
JACC. Heart Failure|April 2, 2021
Reply: Mitral Regurgitation in Acute Decompensated Heart FailureSameer Arora, John P Vavalle
Annals of Internal Medicine|December 22, 2010
ACP Journal Club. Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related deathJohn P Vavalle, L Kristin Newby
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Cardiovascular Diagnosis and Therapy|March 17, 2020
Percutaneous structural and valvular heart disease interventionsJohn P Vavalle, Sameer Arora
Journal of Thrombosis and Thrombolysis|January 19, 2026
Refining the evidence base for anticoagulation in HALT following TAVRSpencer Ng, John P Vavalle
Journal of Thoracic Disease|June 16, 2017
Minimally invasive aortic valve replacement-where are we?Sameer Arora, John P Vavalle
JACC. Heart Failure|April 30, 2021
Reply: Mitral Regurgitation in Heart Failure: Prognostic Significance and Impact on Evaluation of Left Ventricular FunctionSameer Arora, John P Vavalle
Annals of Cardiothoracic Surgery|October 25, 2017
Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidenceSameer Arora, John P Vavalle
JACC. Cardiovascular Interventions|October 23, 2020
Atrial Fibrillation: Not an Innocent Bystander in the Treatment of Functional Mitral RegurgitationJohn P Vavalle, Sameer Arora
Trends in Cardiovascular Medicine|November 8, 2020
Editorial commentary: Asymptomatic aortic stenosis, moderate aortic stenosis with systolic heart failure and bicuspid aortic valve stenosis- is TAVR ready for prime time?Sameer Arora, John P Vavalle
Trends in Cardiovascular Medicine|September 9, 2017
Editorial commentary: TAVR-Is there a path to an all-surgical-risk indication?Sameer Arora, John P Vavalle
JACC. Heart Failure|April 2, 2021
Reply: Mitral Regurgitation in Acute Decompensated Heart FailureSameer Arora, John P Vavalle
Annals of Internal Medicine|December 22, 2010
ACP Journal Club. Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related deathJohn P Vavalle, L Kristin Newby
Pageof 10